VanEck Biotech ETF
BBH
BBH
100 hedge funds and large institutions have $127M invested in VanEck Biotech ETF in 2025 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 15 increasing their positions, 36 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
58% less repeat investments, than reductions
Existing positions increased: 15 | Existing positions reduced: 36
67% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 15
Holders
100
Holding in Top 10
–
Calls
$2.61M
Puts
$205K
Top Buyers
| 1 | +$659K | |
| 2 | +$268K | |
| 3 | +$250K | |
| 4 |
Wealthfront Advisers
Palo Alto,
California
|
+$229K |
| 5 |
SFS
Strategic Financial Services
Utica,
New York
|
+$203K |
Top Sellers
| 1 | -$6.6M | |
| 2 | -$2.5M | |
| 3 | -$2.31M | |
| 4 |
Wells Fargo
San Francisco,
California
|
-$2.19M |
| 5 |
CIG
Consolidated Investment Group
Englewood,
Colorado
|
-$1.76M |
